Literature DB >> 26818418

Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease.

Bonney Reed-Knight1, Jennifer L Lee, Rachel N Greenley, Jeffery D Lewis, Ronald L Blount.   

Abstract

BACKGROUND: Health-related quality of life (HRQoL) is a multidimensional constructinfluenced by disease, individual, and environmental factors. Greater disease activity (DA) predicts poorer HRQoL, but disease status alone does not fully account for individual variability in HRQoL. This investigation tested the role of patient and caregiver internalizing symptoms in explaining the relationship between DA and patient HRQoL.
METHODS: Participants included 83 subjects aged 11 to 18 diagnosed with inflammatory bowel disease and their caregiver. Patients reported on their HRQoL. Caregivers rated their own depressive symptoms and patients' internalizing symptoms (depression, anxiety, and somatization). Physicians rated DA.
RESULTS: Greater DA was positively associated with subjects' internalizing symptoms and negatively associated with HRQoL. Mediation analyses found support for significant indirect effects on the relationship between DA and HRQoL through the subjects' internalizing symptoms, through their internalizing symptoms and caregivers' depressive symptoms, sequentially.
CONCLUSIONS: Greater DA independently relates to poorer HRQoL. In addition, DA relates to greater child internalizing problems which in turn relate to higher levels of caregiver depressive symptoms and poorer HRQoL. Providers may consider a family-based approach to screen for internalizing problems, especially in patients with active disease, because caregiver and child mood symptoms may partially explain worsening child HRQoL.

Entities:  

Mesh:

Year:  2016        PMID: 26818418     DOI: 10.1097/MIB.0000000000000686

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

1.  The Combined Effects of Youth and Parent Illness Intrusiveness on Depressive Symptoms in Adolescents with Inflammatory Bowel Disease.

Authors:  Clayton S Edwards; Caroline M Roberts; Marissa N Baudino; Nathan L Basile; Kaitlyn L Gamwell; Noel J Jacobs; Jeanne Tung; John E Grunow; Larry L Mullins; John M Chaney
Journal:  J Clin Psychol Med Settings       Date:  2022-06-06

2.  Pain and quality of life in youth with inflammatory bowel disease: the role of parent and youth perspectives on family functioning.

Authors:  Line Caes; Christine T Chambers; Anthony Otley; Jennifer Stinson
Journal:  Pain Rep       Date:  2019-02-26

3.  Illness Perceptions and Depression Are Associated with Health-Related Quality of Life in Youth with Inflammatory Bowel Disease.

Authors:  Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Alexander G Bodelier; Herbert M van Wering; Pamela C W M Hurkmans; M Luisa Mearin; Andrea E van der Meulen-de Jong; Johanna C Escher; Elisabeth M W J Utens
Journal:  Int J Behav Med       Date:  2019-08

4.  The health-related quality of life of children with multiple sclerosis is mediated by the health-related quality of life of their parents.

Authors:  Julia O'Mahony; Brenda Banwell; Audrey Laporte; Adalsteinn Brown; Lady Bolongaita; Amit Bar-Or; E Ann Yeh; Ruth Ann Marrie
Journal:  Mult Scler       Date:  2022-02-07       Impact factor: 5.855

5.  Passive Coping Associations With Self-Esteem and Health-Related Quality of Life in Youth With Inflammatory Bowel Disease.

Authors:  Bonney Reed; Kelly E Rea; Robyn Lewis Claar; Miranda A L van Tilburg; Rona L Levy
Journal:  Front Psychol       Date:  2021-06-24

6.  Depression, anxiety, and loneliness among adolescents and young adults with IBD in the UK: the role of disease severity, age of onset, and embarrassment of the condition.

Authors:  Pamela Qualter; Alison Rouncefield-Swales; Lucy Bray; Lucy Blake; Steven Allen; Chris Probert; Kay Crook; Bernie Carter
Journal:  Qual Life Res       Date:  2020-09-30       Impact factor: 3.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.